跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
易奇瑞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dasabuvir Sodium Tablets
Approved
化学药品
Dasabuvir Sodium Tablets
ABBVIE IRELAND NL B.V.
🇨🇳 National Medical Products Administration
Approval Date
Mar 2, 2018
Approval ID
7MaoUJd9PbR
Company
ABBVIE IRELAND NL B.V.
Type
化学药品
Approval Details
Approval Id
7MaoUJd9PbR
Approval Number
H20181130
Generic Name
达塞布韦钠片
Generic Name En
Dasabuvir Sodium Tablets
Trade Name
易奇瑞
Drug Type
化学药品
Dosage Form
片剂
Reg Date
2018-03-02
Expired Date
2022-09-19
Company Name
ABBVIE IRELAND NL B.V.
Company Address
Maidenhead SL6 4UB,United Kingdom
Production Company Name
ABBVIE IRELAND NL B.V.
Production Company Address
Manorhamilton Road, Sligo, Ireland
Company Detail Path
/organization/abbvie-ireland-nl-b-v
Production Company Detail Path
/organization/abbvie-ireland-nl-b-v
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 2, 2018
Approval ID
7MaoUJd9PbR
Type
化学药品
Back to NMPA Approvals